Skip to main content
. 2012 Sep 1;18(9):PI21–PI28. doi: 10.12659/MSM.883336

Table 1.

The characteristics of the study participants treated with ramipril (n=10.380).

% n
Age [years] 57.8±11.3
 ≤65years [%] 74.2 7707
 >65years [%] 25.8 2689
Gender m/f [%] 50.8/49.2 5269/5111
Smokers [%] 28.9 3000
 Pack years 20±14
BMI [kg/m2] 28.6±4.2
 Overweight [%] 48.2 5005
 Obesity [%] 33.2 3444
Morbidly obese [%] 1.3 133
 Waist circumference [cm] 92±12
Visceral obesity [%] 69.1 7174
 Left arm circumference [cm] 33±8
 Arm circumference >32 cm [%] 49.9 5180
Systolic blood pressure* [mmHg] 149.8±15.6
Diastolic blood pressure* [mmHg] 90.5±10.1
Place of residence [%]
 Rural areas 21.1 2194
 City with population of <50,000 residents 27.9 2900
 City with population of 50,000–200,000 residents 21.6 2240
 City with population of >200,000 residents 29.4 3046
Education [%]
 Basic 9.2 961
 Vocational 28.8 2985
 Secondary 41.7 4330
 Higher 20.3 2104
Co-morbidity [%]
 Diabetes 32.2 3338
 Hypertension 96.4 10002
 Peptic ulcer disease 13.8 1435
 Gastroesophageal reflux disease 15.9 1654
 Chronic obstructive pulmonary disease 8.9 920
 Asthma 4.1 428
 Allergic rhinitis 4.7 491
 Chronic rhinosinusitis 3.1 326
 History of tuberculosis 0.3 28
 Mitral valve disorder 2.1 222
 Thoracic aorta aneurysm 0.5 48
 Mental disease 2.5 260
*

The average of 2 measurements.